F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder

Name of the Condition

• Other Psychoactive Substance Abuse with Psychoactive Substance-Induced Sleep Disorder
• ICD-10 Code: F19.182

Summary

This condition involves the abuse of psychoactive substances not classified in other specific categories, accompanied by sleep disturbances directly induced by the substance use. The abuse pattern is recurrent and leads to clinically significant impairment or distress, with sleep disorder symptoms arising as a direct physiological or psychological effect of the substance.

Causes

The causes can include recreational or non-medical use of psychoactive substances, psychological factors, peer pressure, or environmental influences. The induced sleep disorder results from the substance's direct effects on the central nervous system, rather than from an independent sleep disorder.

Risk Factors

• History of substance use disorders
• Mental health conditions (e.g., depression, anxiety)
• Social or peer influences
• Access to psychoactive substances
• Family history of substance abuse

Symptoms

• Recurrent substance use leading to failure to fulfill major roles
• Use in hazardous situations (e.g., driving under the influence)
• Increased tolerance or withdrawal symptoms
• Continued use despite social or interpersonal problems
• Sleep disorder symptoms (e.g., insomnia, hypersomnia, disrupted sleep patterns) directly related to substance use

Diagnosis

Diagnosis requires a clinical evaluation to confirm substance abuse and identify sleep disturbances as substance-induced. Criteria include a history of recurrent substance use, evidence of clinically significant impairment, and sleep symptoms that develop during or shortly after substance use, with no better explanation by an independent sleep disorder. Laboratory tests or sleep studies may support the diagnosis.

Treatment Options

Treatment focuses on addressing substance abuse and managing sleep symptoms. Interventions may include substance use counseling, behavioral therapies, and pharmacological management of withdrawal or sleep disturbances. Sleep hygiene education and non-pharmacological approaches (e.g., cognitive-behavioral therapy for insomnia) are often recommended.

Prognosis and Follow-Up

Prognosis depends on the severity of substance abuse and response to treatment. Regular follow-up is essential to monitor substance use, sleep symptoms, and overall functioning. Long-term recovery may require ongoing support and relapse prevention strategies.

Complications

Complications can include worsening sleep disturbances, increased risk of accidents due to impaired alertness, and exacerbation of other health conditions. Substance abuse may also lead to social, occupational, or legal problems.

Lifestyle & Prevention

Lifestyle modifications include avoiding psychoactive substances, maintaining regular sleep schedules, and reducing stress. Prevention strategies focus on education about substance risks and early intervention for at-risk individuals.

When to Seek Professional Help

Seek professional help if substance use is causing sleep problems, impairment in daily life, or if withdrawal symptoms occur. Immediate care is needed for severe symptoms, such as extreme drowsiness or suicidal thoughts.

Tips for Medical Coders

Document the specific psychoactive substance involved and confirm the sleep disorder is directly induced by the substance. Ensure clinical notes support the diagnosis and differentiate it from independent sleep disorders. Code F19.182 is appropriate when the sleep disorder is the primary induced condition.